Shanghai, China

Aidong Qu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Aidong Qu and His Contribution to Biopharmaceutical Innovation

Introduction: Aidong Qu is a prominent inventor located in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals with his innovative work on monoclonal antibodies, particularly in relation to HER3-related diseases. His efforts have led to the development of valuable medical applications that hold promise for treatment and prevention.

Latest Patents: Aidong Qu holds a patent for an anti-HER3 humanized monoclonal antibody. This groundbreaking invention provides a high-affinity and biologically active antibody that binds to the HER3 antigen. It exhibits low immunogenicity and structural stability, making it an essential candidate for the preparation of drugs aimed at preventing or treating diseases associated with HER3.

Career Highlights: Aidong Qu works at the Shanghai Institute of Biological Products Co., Ltd., a well-respected organization in the realm of biological research and development. His expertise and innovative spirit have contributed to the advancement of therapeutic interventions in the medical field.

Collaborations: Throughout his career, Aidong has collaborated with esteemed colleagues such as Hongyuan Liang and Fanhong Xu. These partnerships have fostered an environment of creativity and innovation, essential for the successful development of new biomedical solutions.

Conclusion: Aidong Qu's work on the anti-HER3 humanized monoclonal antibody highlights the importance of innovation in the biopharmaceutical industry. His contributions not only serve as a beacon of hope for those affected by HER3-related diseases but also reflect the collaborative spirit of scientific research in Shanghai and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…